28660748|t|Angiotensin II subtype 1a receptor signaling in resident hepatic macrophages induces liver metastasis formation.
28660748|a|Liver metastases from colorectal cancer (CRC) are a clinically significant problem. The renin-angiotensin system is involved in tumor growth and metastases. This study was designed to evaluate the role of angiotensin II subtype receptor 1a (AT1a) in the formation of liver metastasis in CRC. A model of liver metastasis was developed by intrasplenic injection of mouse colon cancer (CMT-93) into AT1a knockout mice (AT1aKO) and wild-type (C57BL/6) mice (WT). Compared with WT mice, the liver weight and liver metastatic rate were significantly lower in AT1aKO. The mRNA levels of CD31, transforming growth factor- b1 (TGF-b1), and F4/80 were suppressed in AT1aKO compared with WT. Double immunofluorescence analysis showed that the number of accumulated F4/80(+) cells expressing TGF-b1 in metastatic areas was higher in WT than in AT1aKO. The AT1aKO bone marrow (BM) (AT1aKO-BM)>WT showed suppressed formation of liver metastasis compared with WT-BM>WT. However, the formation of metastasis was further suppressed in WT-BM>AT1aKO compared with AT1aKO-BM>WT. In addition, accumulated F4/80(+) cells in the liver metastasis were not BM-derived F4/80(+) cells, but mainly resident hepatic F4/80(+) cells, and these resident hepatic F4/80(+) cells were positive for TGF-b1. Angiotensin II enhanced TGF-b1 expression in Kupffer cells. Treatment of WT with clodronate liposomes suppressed liver metastasis by diminishing TGF-b1(+) F4/80(+) cells accumulation. The formation of liver metastasis correlated with collagen deposition in the metastatic area, which was dependent on AT1a signaling. These results suggested that resident hepatic macrophages induced liver metastasis formation by induction of TGF-b1 through AT1a signaling.
28660748	0	34	Angiotensin II subtype 1a receptor	GeneOrGeneProduct	11607
28660748	85	101	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	113	129	Liver metastases	DiseaseOrPhenotypicFeature	D008113
28660748	135	152	colorectal cancer	DiseaseOrPhenotypicFeature	D015179
28660748	154	157	CRC	DiseaseOrPhenotypicFeature	D015179
28660748	201	206	renin	GeneOrGeneProduct	19701
28660748	207	218	angiotensin	GeneOrGeneProduct	11606
28660748	241	246	tumor	DiseaseOrPhenotypicFeature	D009369
28660748	258	268	metastases	DiseaseOrPhenotypicFeature	D009362
28660748	318	352	angiotensin II subtype receptor 1a	GeneOrGeneProduct	11607
28660748	354	358	AT1a	GeneOrGeneProduct	11607
28660748	380	396	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	400	403	CRC	DiseaseOrPhenotypicFeature	D015179
28660748	416	432	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	476	481	mouse	OrganismTaxon	10090
28660748	482	494	colon cancer	DiseaseOrPhenotypicFeature	D015179
28660748	496	502	CMT-93	CellLine	CVCL_1986
28660748	509	513	AT1a	GeneOrGeneProduct	11607
28660748	523	527	mice	OrganismTaxon	10090
28660748	529	533	AT1a	GeneOrGeneProduct	11607
28660748	552	559	C57BL/6	CellLine	CVCL_5746
28660748	561	565	mice	OrganismTaxon	10090
28660748	589	593	mice	OrganismTaxon	10090
28660748	616	632	liver metastatic	DiseaseOrPhenotypicFeature	D008113
28660748	666	670	AT1a	GeneOrGeneProduct	11607
28660748	693	697	CD31	GeneOrGeneProduct	18613
28660748	699	729	transforming growth factor- b1	GeneOrGeneProduct	21803
28660748	731	737	TGF-b1	GeneOrGeneProduct	21803
28660748	744	749	F4/80	GeneOrGeneProduct	13733
28660748	769	773	AT1a	GeneOrGeneProduct	11607
28660748	867	872	F4/80	GeneOrGeneProduct	13733
28660748	893	899	TGF-b1	GeneOrGeneProduct	21803
28660748	945	949	AT1a	GeneOrGeneProduct	11607
28660748	957	961	AT1a	GeneOrGeneProduct	11607
28660748	982	986	AT1a	GeneOrGeneProduct	11607
28660748	1027	1043	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	1094	1104	metastasis	DiseaseOrPhenotypicFeature	D009362
28660748	1137	1141	AT1a	GeneOrGeneProduct	11607
28660748	1158	1162	AT1a	GeneOrGeneProduct	11607
28660748	1197	1202	F4/80	GeneOrGeneProduct	13733
28660748	1219	1235	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	1256	1261	F4/80	GeneOrGeneProduct	13733
28660748	1300	1305	F4/80	GeneOrGeneProduct	13733
28660748	1343	1348	F4/80	GeneOrGeneProduct	13733
28660748	1376	1382	TGF-b1	GeneOrGeneProduct	21803
28660748	1384	1398	Angiotensin II	GeneOrGeneProduct	11606
28660748	1408	1414	TGF-b1	GeneOrGeneProduct	21803
28660748	1465	1475	clodronate	ChemicalEntity	D004002
28660748	1497	1513	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	1529	1535	TGF-b1	GeneOrGeneProduct	21803
28660748	1539	1544	F4/80	GeneOrGeneProduct	13733
28660748	1585	1601	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	1618	1626	collagen	GeneOrGeneProduct	12842
28660748	1685	1689	AT1a	GeneOrGeneProduct	11607
28660748	1767	1783	liver metastasis	DiseaseOrPhenotypicFeature	D008113
28660748	1810	1816	TGF-b1	GeneOrGeneProduct	21803
28660748	1825	1829	AT1a	GeneOrGeneProduct	11607
28660748	Association	19701	D009369	No
28660748	Association	19701	D009362	No
28660748	Association	19701	11606	No
28660748	Association	12842	11607	Novel
28660748	Association	D008113	12842	Novel
28660748	Negative_Correlation	D004002	D008113	Novel
28660748	Association	11606	D009369	No
28660748	Association	11606	D009362	No
28660748	Positive_Correlation	11606	21803	Novel
28660748	Positive_Correlation	13733	11607	Novel
28660748	Association	21803	D008113	Novel
28660748	Positive_Correlation	21803	11607	Novel
28660748	Association	11607	D008113	Novel
28660748	Positive_Correlation	18613	11607	Novel